ArticleCardiovascular research2009

Rosiglitazone inhibits hypercholesterolaemia-induced myeloperoxidase upregulation--a novel mechanism for the cardioprotective effects of PPAR agonists.

Hui-Rong Liu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.